Press release
Major Market Shift in Egrifta (Tesamorelin Acetate) Industry: Resumption Of Synthetic Peptide Drug Production And Supply Management In The HIV-Related Lipodystrophy Market
Egrifta (Tesamorelin Acetate) Market Size
In recent years, the market size for egrifta (tesamorelin acetate) has been growing at a rate of $XX. It is predicted to escalate from $XX million in 2024 to $XX million in 2025, marking a Compound Annual Growth Rate (CAGR) of $XX%. This growth during the historic period is due to factors such as heightened awareness about HIV-related complications, increased demand for drug treatment, the rising rate of antiretroviral therapy usage, an enhanced emphasis on quality of life, advancements in medical research and improved public consciousness.
The market size for egrifta (tesamorelin acetate) is predicted to experience a $XX FCAGR over the coming years. By 2029, it's projected to have expanded to a value of $XX million, thanks to a compound annual growth rate (CAGR) of $XX%. The projected expansion during this forecast period can be linked to the rising incidences of chronic illnesses, the growing number of medical facilities, a heightened demand for superior body health tracking tools, the increasing frequency of metabolic malfunctions, and an improved cognizance for disease therapies. Significant trends projected to be seen within the forecast period encompass a rising embrace of targeted treatments, incorporation into thorough care strategies, expansion in personalized medicine, improved patient assistance programs, and an upswing in research initiatives.
What Is Driving the Growth Trajectory of the Egrifta (Tesamorelin Acetate) Market?
The future expansion of the egrifta (tesamorelin acetate) market is significantly influenced by the growing incidence of human immunodeficiency virus (HIV) infections. These instances are described as scenarios where individuals have been contracted with HIV, leading to a gradual decline in their immune system's strength over time. The rise of HIV could be attributed partially to inadequate knowledge and education about preventative strategies such as the use of condoms and routine testing, especially among populations at a higher risk. Egrifta is effective in improving body composition and reducing surplus visceral fat by triggering the secretion of growth hormone, thereby improving overall health and life quality for people living with HIV. For instance, in May 2024, the Minnesota Department of Health, an American state health agency, reported an increase of 24% from 2022, with 324 new HIV diagnoses in 2023. Therefore, the escalation in the number of human immunodeficiency virus (HIV) infections is fueling the growth of the egrifta (tesamorelin acetate) market.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20043&type=smp
Which Leading Companies Are Shaping the Growth of the Egrifta (Tesamorelin Acetate) Market?
Major companies operating in the egrifta (tesamorelin acetate) market include Theratechnologies Inc.
What Are the Major Trends Shaping the Egrifta (Tesamorelin Acetate) Market?
One of the main trends in the egrifta (tesamorelin acetate) market is the focus on developing superior synthetic peptide drugs to improve the effectiveness of treatments for HIV-related lipodystrophy. These synthetic peptide drugs are carefully crafted compounds aimed at delivering specific therapeutic impacts by either imitating or enhancing the functions of naturally present peptides. For example, Theratechnologies Inc., a biopharmaceutical firm based in Canada, announced in December 2024 that it had restarted EGRIFTA SV production following a voluntary closure of its contract manufacturer's facility due to FDA inspection findings. A newly produced batch has passed quality checks and is awaiting U.S Food and Drug Administration (FDA) approval of a prior approval supplement. Additionally, two more batches are currently being produced. The firm is managing inventory to ensure patient needs are met until mid-January 2025 and collaborating with the FDA to avoid a supply shortage in 2025. EGRIFTA SV is solely distributed in the United States.
What Are the Key Segments of the Egrifta (Tesamorelin Acetate) Market?
The egrifta (tesamorelin acetate) market covered in this report is segmented -
1) By Clinical Indication: Human Immunodeficiency Virus (HIV)-Associated Lipodystrophy, Growth Hormone Deficiency, Abdominal Obesity, Metabolic Syndrome
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
3) By End-Users: Hospitals, Specialized Clinics, Home Care
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/egrifta-tesamorelin-acetate-global-market-report
Which Region Dominates the Egrifta (Tesamorelin Acetate) Market?
North America was the largest region in the egrifta (tesamorelin acetate) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the egrifta (tesamorelin acetate) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
What Is Covered In The Egrifta (Tesamorelin Acetate) Global Market Report?
- Market Size Analysis: Analyze the egrifta (tesamorelin acetate) Market Size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the egrifta (tesamorelin acetate) market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall egrifta (tesamorelin acetate) market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the egrifta (tesamorelin acetate) market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20043
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Major Market Shift in Egrifta (Tesamorelin Acetate) Industry: Resumption Of Synthetic Peptide Drug Production And Supply Management In The HIV-Related Lipodystrophy Market here
News-ID: 3872844 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Egrifta
Rising HIV Prevalence Fuels Growth In The Egrifta (Tesamorelin Acetate) Market: …
The Egrifta (Tesamorelin Acetate) Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Egrifta (Tesamorelin Acetate) Market Size and Its Estimated Growth Rate?
The market size for egrifta (tesamorelin acetate) has experienced a HCAGR of XX in the past few years. Predictions indicate…
Comprehensive Egrifta (Tesamorelin Acetate) Market Insights: Forecasting Size, G …
What industry-specific factors are fueling the growth of the egrifta (tesamorelin acetate) market?
The surge in human immunodeficiency virus (HIV) incidences is substantially spurring the expansion of the egrifta (tesamorelin acetate) market going forward. HIV cases encompass situations where people are infected with HIV, thereby steadily eroding their immune response. The increasing occurrence of HIV can be attributed in part to inadequate awareness and understanding regarding preventive strategies, such as the…
Lipodystrophy Market Expected to rise, 2034 | Ionis Pharmaceuticals, Regeneron P …
The Lipodystrophy market growth is driven by factors like increase in the prevalence of Lipodystrophy, investments in research and development, entry of emerging therapies during the study period 2020-2034.
The Lipodystrophy market report [https://www.delveinsight.com/report-store/lipodystrophy-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr] also offers comprehensive insights into the Lipodystrophy market size, share, Lipodystrophy epidemiology, emerging therapies, market drivers and barriers, ongoing clinical trials, key collaboration in the space, market uptake by key therapies and companies actively pushing Lipodystrophy market…
Lipodystrophy Market Size in the 7MM is expected to grow by 2034, estimates Delv …
DelveInsight's "Lipodystrophy Market Insights, Epidemiology and Market Forecast - 2034" report delivers an in-depth understanding of the indication Lipodystrophy, historical and forecasted epidemiology as well as the Lipodystrophy market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.
Discover Key Insights into the Lipodystrophy Market with DelveInsight's In-Depth Report @ Lipodystrophy Market Size [https://www.delveinsight.com/sample-request/lipodystrophy-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Lipodystrophy Market Report
* In November…
Detailed Review of Forecasted Lipodystrophy Market is included in the report cov …
The Lipodystrophy Market is expected to experience a positive growth in the coming years, owing to the advancements in research and development. The key driver for the surge in Lipodystrophy market size is the rise in the number of the cases for Lipodystrophy and the rise in awareness of the disease.
The Lipodystrophy market report provides current treatment practices, Lipodystrophy emerging drugs, market share of the individual therapies, and the current…
HIV-Associated Lipodystrophy Treatment Market - Increasing prevalence of HIV is …
HIV-associated lipodystrophy also known as lipodystrophy is a syndrome that occurs in HIV-infected patients. It is characterized by loss of subcutaneous fat from face, buttocks, arms and legs. Although the exact cause of HIV-associated lipodystrophy is not fully elucidated, some research evidence reported that it occurs in HIV-infected patients who are under antiretroviral medications. According to an article published in National Center for Biotechnology Information (NCBI) in 2014, prevalence of…
